ClinicalTrialsFinder

Neuromyelitis Optica Spectrum Disorders Clinical Trials in Cangzhou

1 recruitingCangzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled51 locationsNCT06413654